SMURF2 and glioblastoma: Moreover, SMURF2Thr249 phosphorylation was markedly lower in the GBM pathology specimens, accompanied by no marked alteration in the SMURF2 protein level, irrespective of the unknown mechanism of downregulated SMURF2Thr249 phosphorylation in GBM patients.